SCHEMBL6465427

SCHEMBL6465427

Cc1ccc(Oc2cc(-c3ccc(-c4ncc[nH]4)cc3)oc2-c2ccc(-c3ncc[nH]3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NISCH Q9Y2I1 2/20 0.55
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP19A1 P11511 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ PTPN1 P18031 2/20 0.38
▸ MTOR P42345 1/20 0.37
▸ ADK P55263 1/20 0.37
▸ SMPD3 Q9NY59 1/20 0.36
▸ ADRA2A P08913 2/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ MET P08581 1/20 0.35
▸ PTPN2 P17706 1/20 0.34
▸ PTPN6 P29350 1/20 0.34
▸ MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5335304 0.82 SMPD3 (0.51) NISCHCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL7734244 0.77 MAOB (0.47) ALDH1A1PTPN1KCNH2PTPN2PTPN6
SCHEMBL5310372 0.75 NISCH (0.56) NISCHCYP1A2ALDH1A1MAOB
Hydrochloric Acid SCHEMBL10466228 0.75 NISCH (0.64) NISCHCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL674010 0.74 NISCH (1.00) NISCHCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL7732923 0.74 AR (0.51) CYP3A4ALDH1A1PTPN1KCNH2MAOB
SCHEMBL28230038 0.72 NISCH (0.96) NISCHCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL28110769 0.72 NISCH (0.96) NISCHCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL27451043 0.72 NISCH (0.96) NISCHCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL27974204 0.72 NISCH (0.96) NISCHCYP1A2CYP3A4CYP2D6CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1545544-A2 COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS Combinatorx, Incorporated (US) 2005-06-29 — — EP disclosed
WO-2004006842-A2 COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS COMBINATORX, INCORPORATED (US) 2004-01-22 — — WO disclosed
Send feedback